⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzimidazole SCHEMBL10931770 | 1.00 | SMN1; SMN2 (0.50) | — | |
| Benzimidazole SCHEMBL461969 | 1.00 | SMN1; SMN2 (0.50) | — | |
| Benzimidazole SCHEMBL29408372 | 1.00 | — | — | |
| Benzimidazole SCHEMBL6009 | 1.00 | — | — | |
| Benzimidazole SCHEMBL23673327 | 0.97 | SMN1; SMN2 (0.48) | — | |
| Benzimidazole SCHEMBL20531480 | 0.97 | SMN1; SMN2 (0.48) | — | |
| Benzimidazole SCHEMBL5131535 | 0.97 | — | — | |
| Benzimidazole SCHEMBL22551123 | 0.97 | SMN1; SMN2 (0.48) | — | |
| Benzimidazole SCHEMBL21046391 | 0.97 | — | — | |
| Benzimidazole SCHEMBL9589943 | 0.97 | SMN1; SMN2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2927 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122089949-A | Interactive control method for digital modeling of historical architecture, electronic equipment and computer program product | — | 2026-05-26 | — | — | CN | claimed |
| CN-116209679-B | Antibody-drug conjugates containing anti-mesothelin antibodies and uses thereof | BIOTECHNOLOGY DEVELOPMENT CENTER (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260132147-A1 | BAX INHIBITORS AND USES THEREOF | CASE WESTERN RESERVE UNIV (US) | 2026-05-14 | — | — | US | claimed |
| US-12624045-B2 | Condensed cyclic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-05-12 | — | — | US | claimed |
| EP-3985750-B1 | LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| EP-4727950-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS | GlaxoSmithKline Intellectual Property Development Ltd (GB) | 2026-04-22 | — | — | EP | claimed |
| US-12606744-B2 | Zinc pigment for waterborne corrosion coatings | SUN CHEMICAL CORPORATION (US) | 2026-04-21 | — | — | US | claimed |
| EP-4720041-A2 | N-(1H-INDOL-2-YL)METHYL)-4-ETHYNYL-PICOLINAMIDE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | Allorion Therapeutics Inc (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4719382-A1 | INHIBITORS OF TYPE 1 METHIONYL-TRNA SYNTHETASE AND METHODS OF USING THEM | University of Washington (US) | 2026-04-08 | — | — | EP | claimed |
| CN-114054099-A | Fe3O4@SiO2-2N-CoCl2Catalyst, preparation method and application thereof | 万华化学集团股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-108511613-B | Organic light emitting device | 三星电子株式会社 | 2022-02-18 | — | — | CN | claimed |
| US-20220052276-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-02-17 | — | — | US | claimed |
| US-20220052264-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-02-17 | — | — | US | claimed |
| WO-2022029628-A1 | COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2022-02-10 | — | — | WO | claimed |
| EP-3475285-B1 | MECHANISTIC TARGET OF RAPAMYCIN SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF | SUZHOU KINTOR PHARMACEUTICALS INC (CN) | 2022-02-09 | — | — | EP | claimed |
| US-11242346-B2 | Mechanistic target of rapamycin signaling pathway inhibitors and therapeutic applications thereof | SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) | 2022-02-08 | — | — | US | claimed |
| CN-114014846-A | Method for regioselectively synthesizing indene-indole derivative | 兰州大学 | 2022-02-08 | — | — | CN | claimed |
| US-20220033375-A1 | NOVEL CONFORMATIONALLY-RESTRICTED ANALOGUES OF SORAFENIB AND REGORAFENIB AS SELECTIVE KINASE INHIBITORS FOR CANCER TREATMENT | UNIVERSITY OF SHARJAH (AE) | 2022-02-03 | — | — | US | claimed |
| WO-2022020247-A1 | SMALL MOLECULE CORRECTORS OF MAMMALIAN SLC6A8 FUNCTION | JNANA THERAPEUTICS, INC. (US) | 2022-01-27 | — | — | WO | claimed |